Financials in GBp. Standardized financial statements.
A compact view of how Alliance Pharma plc turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | £178.84M | £180.68M | £167.42M | £163.21M | £129.80M | £135.64M | £118.21M | £103.31M | £97.49M | £48.34M |
| Revenue Growth? | -1.0% | +7.9% | +2.6% | +25.7% | -4.3% | +14.7% | +14.4% | +6.0% | +101.7% | 0.0% |
| Cost of Revenue? | £69.55M | £75.66M | £65.73M | £53.76M | £46.98M | £49.56M | £45.56M | £44.35M | £42.64M | £19.61M |
| Gross Profit? | £109.29M | £105.02M | £101.68M | £109.45M | £82.82M | £86.08M | £72.65M | £58.96M | £54.85M | £28.73M |
| Gross Margin? | +61.1% | +58.1% | +60.7% | +67.1% | +63.8% | +63.5% | +61.5% | +57.1% | +56.3% | +59.4% |
| Operating Expenses? | £117.38M | £143.46M | £72.88M | £81.72M | £54.44M | £48.63M | £43.72M | £33.16M | £29.54M | £11.77M |
| Operating Income? | -£8.10M | -£38.44M | £28.43M | £21.57M | £16.32M | £35.63M | £23.67M | £26.31M | £25.61M | £16.96M |
| EBITDA? | £3.86M | -£28.94M | -£7.50M | £31.27M | £36.06M | £36.04M | £33.63M | £32.76M | £25.57M | £17.21M |
| Income Before Tax | -£14.46M | -£48.80M | £5.21M | £18.16M | £13.02M | £31.08M | £22.80M | £28.37M | £22.22M | £15.18M |
| Income Tax Expense | -£3.73M | -£15.66M | £4.27M | £10.84M | £4.99M | £6.07M | £4.45M | -£541,000 | £4.13M | £2.49M |
| Net Income? | -£10.73M | -£33.14M | -£21.21M | £7.32M | £8.03M | £25.01M | £18.36M | £28.91M | £18.09M | £12.69M |
| EPS? | £-0.02 | £-0.06 | £0.00 | £0.01 | £0.02 | £0.05 | £0.04 | £0.06 | £0.04 | £0.05 |
| Diluted EPS? | £-0.02 | £-0.06 | £0.00 | £0.01 | £0.02 | £0.05 | £0.04 | £0.06 | £0.04 | £0.05 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality